Circulating levels of TNF and TNFR are elevated in patients with alcoholic liver disease and alcoholic steatohepatitis, while treatment with anti TNF antibodies protects against alcoholic liver injury in animal models [60,70]. This evidence concerns the gene TNFRSF1A and alcoholic fatty liver disease.